Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,056	1,169	775.39	575.11	453.97
Short-Term Investments	-	-	-	-	410
Trading Asset Securities	150.13	160.06	-	-	370.32
Cash & Short-Term Investments	1,206	1,329	775.39	575.11	1,234
Cash Growth	-9.23%	71.37%	34.82%	-53.41%	0.91%
Accounts Receivable	1,077	883.9	803.79	569.97	487.61
Other Receivables	40.35	46.79	47.14	78.5	68.54
Receivables	1,117	930.69	850.93	648.47	556.16
Inventory	271.61	281.29	346	259.95	223.9
Prepaid Expenses	22.55	-	-	-	-
Other Current Assets	112.53	100.02	81.32	64.9	81.38
Total Current Assets	2,730	2,641	2,054	1,548	2,096
Property, Plant & Equipment	917.09	996.04	1,074	1,137	1,126
Long-Term Investments	146.99	232.46	422.17	381.19	398.83
Other Intangible Assets	1,277	751.23	708.33	682.47	599.98
Long-Term Deferred Tax Assets	177.23	148.24	126.08	83.57	80.6
Long-Term Deferred Charges	1,107	1,427	1,233	822.42	587.16
Other Long-Term Assets	443.95	457.37	430.15	350.51	108.15
Total Assets	6,798	6,653	6,048	5,005	4,997
Accounts Payable	195.89	208.99	242.44	301.4	419.95
Accrued Expenses	190.48	200.09	136.68	120.63	93.13
Short-Term Debt	242.57	99.98	484.69	452.18	740
Current Portion of Long-Term Debt	728.41	833.59	295.4	325.78	-
Current Portion of Leases	10.27	7.41	6.64	8	-
Current Income Taxes Payable	5.49	16.08	16.1	1.71	47.73
Current Unearned Revenue	20.87	14.61	26.96	28.44	26.02
Other Current Liabilities	174.23	123.23	279.64	279.98	389.4
Total Current Liabilities	1,568	1,504	1,489	1,518	1,716
Long-Term Debt	925	854.68	1,320	452.41	334.9
Long-Term Leases	4.14	10.85	4.52	10.91	-
Long-Term Unearned Revenue	95.06	108.47	98.52	102.54	87.14
Long-Term Deferred Tax Liabilities	3.77	4.01	2.53	1.11	1.33
Other Long-Term Liabilities	-	0.38	-	-	2.23
Total Liabilities	2,596	2,482	2,914	2,085	2,142
Common Stock	1,120	1,114	1,076	1,077	1,074
Additional Paid-In Capital	953.57	853.38	100.82	97.62	78.57
Retained Earnings	2,180	2,210	1,807	1,733	1,787
Treasury Stock	-80.94	-9.15	-24.44	-38.31	-24.76
Comprehensive Income & Other	40.55	11.86	76.41	-26.82	-13.3
Total Common Equity	4,213	4,180	3,036	2,842	2,902
Minority Interest	-11.09	-9.36	97.68	78.27	-47.65
Shareholders' Equity	4,202	4,171	3,133	2,920	2,855
Total Liabilities & Equity	6,798	6,653	6,048	5,005	4,997
Total Debt	1,910	1,807	2,111	1,249	1,075
Net Cash (Debt)	-704.22	-477.74	-1,336	-674.16	159.39
Net Cash Growth	-	-	-	-	11.29%
Net Cash Per Share	-0.62	-0.44	-1.25	-0.63	0.15
Filing Date Shares Outstanding	1,159	1,048	1,036	1,091	1,137
Total Common Shares Outstanding	1,159	1,048	1,036	1,091	1,137
Working Capital	1,162	1,137	565.09	30.32	379.5
Book Value Per Share	3.63	3.99	2.93	2.61	2.55
Tangible Book Value	2,937	3,429	2,327	2,159	2,302
Tangible Book Value Per Share	2.53	3.27	2.25	1.98	2.03
Buildings	931.33	965.52	922.14	931.62	684.59
Machinery	789.01	748.62	709.94	677.15	602.24
Construction In Progress	6.73	5.87	97.9	88.54	335.2

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.